Pharmaceutical Grade Timolol Maleate Market Size, Analyzing Shifts and Predicted Scenarios 2024-2031 Artrocker - Artrocker
| 1777 Stock | TWD 94.40 0.80 0.85% |
Slightly above 51% of SYN Tech's investor base is interested to short. The analysis of current outlook of investing in SYN Tech Chem Pharm suggests that many traders are impartial regarding SYN Tech's prospects. SYN Tech's investing sentiment can be driven by a variety of factors including economic data, SYN Tech's earnings reports, geopolitical events, and overall market trends.
SYN Tech stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of SYN daily returns and investor perception about the current price of SYN Tech Chem Pharm as well as its diversification or hedging effects on your existing portfolios.
SYN |
Pharmaceutical Grade Timolol Maleate Market Size, Analyzing Shifts and Predicted Scenarios 2024-2031 Artrocker Artrocker
Read at news.google.com
 |
SYN Tech Fundamental Analysis
We analyze SYN Tech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SYN Tech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SYN Tech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
SYN Tech is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
SYN Tech Chem Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SYN Tech stock to make a market-neutral strategy. Peer analysis of SYN Tech could also be used in its relative valuation, which is a method of valuing SYN Tech by comparing valuation metrics with similar companies.
Peers
SYN Tech Related Equities
| 4162 | PharmaEngine | 3.26 | ||||
| 6541 | Tanvex BioPharma | 1.91 | ||||
| 4147 | TaiMed Biologics | 1.70 | ||||
| 6589 | EirGenix | 1.65 | ||||
| 4174 | OBI Pharma | 0.87 | ||||
| 6547 | Medigen Vaccine | 0.85 | ||||
| 1760 | Panion BF | 0.24 | ||||
| 6712 | Ever Supreme | 0.28 | ||||
| 4142 | Adimmune Corp | 0.50 |
Additional Tools for SYN Stock Analysis
When running SYN Tech's price analysis, check to measure SYN Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SYN Tech is operating at the current time. Most of SYN Tech's value examination focuses on studying past and present price action to predict the probability of SYN Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SYN Tech's price. Additionally, you may evaluate how the addition of SYN Tech to your portfolios can decrease your overall portfolio volatility.